New patent for VIVUS drug QSYMIA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for QSYMIA
Annual Drug Patent Expirations for QSYMIA

Qsymia is a drug marketed by Vivus and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.

QSYMIA drug price trends.

Drug patent litigation for QSYMIA.

This drug has thirty-eight patent family members in seventeen countries.

The generic ingredient in QSYMIA is phentermine hydrochloride; topiramate. One supplier is listed for this compound. Additional details are available on the phentermine hydrochloride; topiramate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top